Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer
Punekar S, Griffin M, Masri L, Roman S, Makarov D, Sherman S, Becker D. Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer. American Journal Of Clinical Oncology 2021, 44: 597-602. PMID: 34753883, DOI: 10.1097/coc.0000000000000875.Peer-Reviewed Original ResearchConceptsStage IV colorectal cancerKRAS testingColorectal cancerMedicaid insuranceMultivariable-adjusted Cox proportional hazards modelsStage IV colorectal adenocarcinomaEpidermal growth factor receptor monoclonal antibodiesCox proportional hazards modelMultivariable logistic regression modelAdvanced colorectal cancerEnd Results (SEER) databaseRisk of deathReceptor monoclonal antibodyProportional hazards modelWild-type KRASSocioeconomic disparities persistLogistic regression modelsCRC patientsResults databaseColorectal adenocarcinomaKRAS mutationsHigher median household incomeHazards modelPatientsMolecular testing